Medical treatment of prolactinomas
- PMID: 10207689
- DOI: 10.1016/s0889-8529(05)70061-x
Medical treatment of prolactinomas
Abstract
Prolactinomas are a common cause of reproductive and sexual dysfunction. Once other causes of hyperprolactinemia have been excluded with a careful history, physical examination, routine chemistries, and a TSH, MR imaging or computerized tomography will delineate the size and extent of the tumor. Medical therapy is the initial treatment of choice. When infertility is the primary indication for treatment, bromocriptine use has an extensive safety experience and is preferred. For other indications, however, cabergoline appears to be more efficacious and better tolerated. Transsphenoidal surgery remains an option, especially for patients with microadenomas, when medical therapy is ineffective.
Similar articles
-
Medical management of prolactin-secreting pituitary adenomas.Pituitary. 2002;5(2):55-65. doi: 10.1023/a:1022375429083. Pituitary. 2002. PMID: 12675502 Review.
-
Disorders of prolactin secretion.Endocrinol Metab Clin North Am. 2001 Sep;30(3):585-610. doi: 10.1016/s0889-8529(05)70203-6. Endocrinol Metab Clin North Am. 2001. PMID: 11571932 Review.
-
Prolactin-secreting tumors: what's new?Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S29-35. doi: 10.1586/14737140.6.9s.S29. Expert Rev Anticancer Ther. 2006. PMID: 17004854 Review.
-
Update on prolactinomas. Part 2: Treatment and management strategies.J Clin Neurosci. 2015 Oct;22(10):1568-74. doi: 10.1016/j.jocn.2015.03.059. Epub 2015 Aug 1. J Clin Neurosci. 2015. PMID: 26243714 Review.
-
Diagnosis and drug therapy of prolactinoma.Drugs. 1996 Jun;51(6):954-65. doi: 10.2165/00003495-199651060-00004. Drugs. 1996. PMID: 8736617 Review.
Cited by
-
Diagnosis and Management of pituitary disease with focus on the role of Magnetic Resonance Imaging.Endocrine. 2020 Jun;68(3):489-501. doi: 10.1007/s12020-020-02242-3. Epub 2020 Mar 11. Endocrine. 2020. PMID: 32162185 Review.
-
The effect of MR contrast medium dose on pituitary gland enhancement, microlesion enhancement and pituitary gland-to-lesion contrast conspicuity.Neuroradiology. 2006 Jul;48(7):449-59. doi: 10.1007/s00234-006-0085-0. Epub 2006 May 3. Neuroradiology. 2006. PMID: 16699802
-
Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists.Pituitary. 2011 Sep;14(3):222-30. doi: 10.1007/s11102-010-0283-y. Pituitary. 2011. PMID: 21170594 Free PMC article.
-
Pituitary apoplexy during treatment of cystic macroprolactinomas with cabergoline.Pituitary. 2008;11(3):287-92. doi: 10.1007/s11102-007-0046-6. Pituitary. 2008. PMID: 17570067
-
Drug-induced Hyperprolactinemia Results in Atypical Atypical Fracture.Hip Pelvis. 2021 Jun;33(2):102-107. doi: 10.5371/hp.2021.33.2.102. Epub 2021 Jun 4. Hip Pelvis. 2021. PMID: 34141697 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical